SCHEMBL4307272

SCHEMBL4307272

Cc1coc(C)c1CO

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20129902 0.71
SCHEMBL8656998 0.70 PDCD1 (0.43)
SCHEMBL4134871 0.70 KDM4E (0.33)
SCHEMBL13841438 0.65
SCHEMBL862533 0.64
SCHEMBL30366318 0.64 GABRA1 (0.40)
SCHEMBL11844587 0.64 IDO1 (0.36)
SCHEMBL3414808 0.64 GABRA1 (0.40)
SCHEMBL15896844 0.60 NQO1 (0.35)
SCHEMBL95192 0.60 HRH3 (0.40)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7582712-B1 Alpha-olefins polymerization catalyst FORMOSA PLASTICS CORPORATION, U.S.A. (US) 2009-09-01 US claimed
US-7582712-B1 Alpha-olefins polymerization catalyst FORMOSA PLASTICS CORPORATION, U.S.A. (US) 2009-09-01 US disclosed
US-20060194969-A1 4-Substituted benzimidazoles and their uses as inhibitors of gastric secretion ALTANA PHARMA AG (DE) 2006-08-31 US disclosed
EP-1575924-A1 4-SUBSTITUTED BENZIMIDAZOLES AND THEIR USE AS INHIBITORS OF GASTRIC SECRETION ALTANA Pharma AG (DE) 2005-09-21 EP disclosed
WO-2004054984-A1 4-SUBSTITUTED BENZIMIDAZOLES AND THEIR USE AS INHIBITORS OF GASTRIC SECRETION ALTANA PHARMA AG (DE) 2004-07-01 WO disclosed
EP-0008665-B1 FURYL-NONATETRAENE DERIVATIVES AND THE PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, PROCESSES FOR THEIR PREPARATION, STARTING COMPOUNDS USED IN THESE PROCESSES, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1983-06-15 EP disclosed
US-4216312-A ANTITUMOR AGENTS, TREATMENT OF ACNE AND PSORIASIS HOFFMANN-LA ROCHE INC. (US) 1980-08-05 US disclosed
EP-0008665-A1 Furyl-nonatetraene derivatives and the pharmaceutically acceptable salts thereof, processes for their preparation, starting compounds used in these processes, and pharmaceutical compositions containing them F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft (CH) 1980-03-19 EP disclosed